Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 2, 2008, Pages 171-178

  Kita, Atsuko ^a   Furukawa, Kiyoshi ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

AC 5216; Anxiolytic effect; Finasteride; Mice; Mitochondrial benzodiazepine receptor (MBR); Neurosteroid; Peripheral benzodiazepine receptor (PBR); Picrotoxin; Social interaction; Translocator protein (18 kDa) (TSPO); Trilostane

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; DIAZEPAM; EMAPUNIL; FINASTERIDE; NEUROSTEROID; PICROTOXIN; PROGESTERONE; TRILOSTANE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SOCIAL INTERACTION; STEROIDOGENESIS; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; DIAZEPAM; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FINASTERIDE; GABA ANTAGONISTS; INTERPERSONAL RELATIONS; MALE; MICE; PICROTOXIN; PREGNANOLONE; PROGESTERONE; PURINES; RECEPTORS, GABA-A;

ANIMALIA; MUS;

EID: 39149102505     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.12.006     Document Type: Article

References (46)

1. Andréen L., Sundström-Poromaa I., Bixo M., Nyberg S., and Bäckström T. Allopregnanolone concentration and mood-a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl) 187 (2006) 209-221
2. Anholt R.R., Murphy K.M., Mack G.E., and Snyder S.H. Peripheral-type benzodiazepine receptors in the central nervous system: localization to olfactory nerves. J Neurosci 4 (1984) 593-603
3. Anholt R.R., Pedersen P.L., De Souza E.B., and Snyder S.H. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261 (1986) 576-583
4. Basile A.S., and Skolnick P. Subcellular localization of "peripheral-type" binding sites for benzodiazepines in rat brain. J Neurochem 46 (1986) 305-308
5. Beurdeley-Thomas A., Miccoli L., Oudard S., Dutrillaux B., and Poupon M.F. The peripheral benzodiazepine receptors: a review. J Neuro-oncol 46 (2000) 45-56
6. Bitran D., Hilvers R.J., and Kellogg C.K. Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561 (1991) 157-161
7. A receptor function. Pharmacol Biochem Behav 45 (1993) 423-428
8. A receptors. J Neuroendocrinol 7 (1995) 171-177
9. Bitran D., Foley M., Audette D., Leslie N., and Frye C.A. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl) 151 (2000) 64-71
10. Brot M.D., Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 325 (1997) 1-7
11. Casellas P., Galiegue S., and Basile A.S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40 (2002) 475-486
12. 3H]PK 11195: anatomical and subcellular distribution. Brain Res Bull 18 (1987) 49-61
13. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuro-psychopharmacol Biol Psychiatry 29 (2005) 169-192
14. Frye C.A. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res Rev 37 (2001) 201-222
15. Frye C.A., and Rhodes M.E. Infusions of 5α-pregnan-3α-ol-20-one (3α,5α-THP) to the ventral tegmental area, but not the substantia nigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3α,5α-THP concentrations in the hippocampus, diencephalon and cortex of ovariectomised oestrogen-primed rats. J Neuroendocrinol 18 (2006) 960-975
16. Frye C.A., Petralia S.M., and Rhodes M.E. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol Biochem Behav 67 (2000) 587-596
17. 3H]Diazepam binding in mammalian central nervous system: a pharmacological characterization. J Neurosci 1 (1981) 218-225
18. Gee K.W., Chang W.C., Brinton R.E., and McEwen B.S. GABA-dependent modulation of the Cl- ionophore by steroids in rat brain. Eur J Pharmacol 136 (1987) 419-423
19. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., and McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246 (1988) 803-812
20. Gomez C., Saldivar-Gonzalez A., Delgado G., and Rodriguez R. Rapid anxiolytic activity of progesterone and pregnanolone in male rats. Pharmacol Biochem Behav 72 (2002) 543-550
21. Kita A., Kohayakawa H., Kinoshita T., Ochi Y., Nakamichi K., Kurumiya S., et al. Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br J Pharmacol 142 (2004) 1059-1072
22. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 288 (1999) 679-684
23. Korneyev A., Pan B.S., Polo A., Romeo E., Guidotti A., and Costa E. Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J Neurochem 61 (1993) 1515-1524
24. Krueger K.E., and Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem 265 (1990) 15015-15022
25. Lambert J.J., Belelli D., Hill-Venning C., and Peters J.A. Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16 (1995) 295-303
26. McCauley L.D., Park C.H., Lan N.C., Tomich J.M., Shively J.E., and Gee K.W. Benzodiazepines and peptides stimulate pregnenolone synthesis in brain mitochondria. Eur J Pharmacol 276 (1995) 145-153
27. Mellon S.H., and Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 13 (2002) 35-43
28. Mohler H., Fritschy J.M., and Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300 (2002) 2-8
29. Papadopoulos V., Amri H., Boujrad N., Cascio C., Culty M., Garnier M., et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62 (1997) 21-28
30. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapere J.J., Lindemann P., et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27 (2006) 402-409
31. Phan V.L., Su T.P., Privat A., and Maurice T. Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect sigma1 receptor-mediated behaviour in mice. Eur J Neurosci 11 (1999) 2385-2396
32. Picazo O., and Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res 680 (1995) 135-141
33. Potts G.O., Creange J.E., Hardomg H.R., and Schane H.P. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 32 (1978) 257-267
34. Przegalinski E., Tatarczynska E., and Chojnacka-Wojcik E. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats. Neuropharmacology 39 (2000) 1858-1864
35. Reddy D.S., and Kulkarni S.K. Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology (Berl) 128 (1996) 280-292
36. Reddy D.S., and Kulkarni S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 752 (1997) 61-71
37. Rhodes M., and Frye C.A. Inhibiting progesterone metabolism in the hippocampus of rats in behevioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behavior. Cogn Affect Behav Neurosci 1 (2001) 287-296
38. Rittmaster R.S. Finasteride. N Engl J Med 330 (1994) 120-125
39. Rittmaster R.S. 5alpha-reductase inhibitors. J Androl 18 (1997) 582-587
40. Rodgers R.J., and Johnson N.J. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol Biochem Behav 59 (1998) 221-232
41. Romeo E., Auta J., Kozikowski A.P., Ma D., Papadopoulos V., Puia G., et al. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J Pharmacol Exp Ther 262 (1992) 971-978
42. 3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res 248 (1982) 396-401
43. Serra M., Madau P., Chessa M.F., Caddeo M., Sanna E., Trapani G., et al. 2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats. Br J Pharmacol 127 (1999) 177-187
44. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63 (2001) 193-213
45. Strous R.D., Maayan R., and Weizman A. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur Neuropsychopharmacol 16 (2006) 155-169
46. Wieland S., Belluzzi J.D., Stein L., and Lan N.C. Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents. Psychopharmacology (Berl) 118 (1995) 65-71